These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10598128)

  • 1. Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations.
    Sugiyama A; Lurie KG; Efange SM; Takehana S; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):843-7. PubMed ID: 10598128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel vesamicol receptor ligand, m-(iodobenzyl)trozamicol, on the canine isolated, blood-perfused atrioventricular node preparation.
    Sugiyama A; Lurie KG; Efange SMN ; Takahara A; Takehana S; Haghimoto K
    Jpn J Pharmacol; 2000 Feb; 82(2):150-4. PubMed ID: 10877534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
    Takehana S; Sugiyama A; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac safety profile of sildenafil: chronotropic, inotropic and coronary vasodilator effects in the canine isolated, blood-perfused heart preparations.
    Lubna NJ; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    J Toxicol Sci; 2016; 41(6):739-744. PubMed ID: 27853102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A; Motomura S; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M; Kamiya J; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K; Wada Y; Taira N
    Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand.
    Coffeen PR; Efange SM; Haidet GC; McKnite S; Langason RB; Khare AB; Pennington J; Lurie KG
    Nucl Med Biol; 1996 Oct; 23(7):923-6. PubMed ID: 8971861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of salmon calcitonin on SA nodal pacemaker activity and contractility in isolated, blood-perfused atrial and papillary muscle preparations of dogs.
    Chiba S; Himori N
    Jpn Heart J; 1977 Mar; 18(2):214-20. PubMed ID: 870729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?
    Gotanda K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):239-46. PubMed ID: 2459556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations.
    Sugiyama A; Yatomi Y; Takahara A; Satoh Y; Hashimoto K
    Jpn J Pharmacol; 2002 Mar; 88(3):359-61. PubMed ID: 11949893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
    Wada Y; Taira N
    Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and tissue distribution of (m-[125I]iodobenzyl)trozamicol ([125I]MIBT): potential radioligand for mapping central cholinergic innervation.
    Efange SM; Michelson RH; Khare AB; Thomas JR
    J Med Chem; 1993 Jun; 36(12):1754-60. PubMed ID: 8510103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.